Roland Diggelmann

Roche’s improved CARDIAC point-of-care Troponin T test now available for countries accepting the CE Mark

The Roche test enables healthcare professionals to identify patients with a suspected heart attack in the pre-hospital setting, helping ensure…

9 years ago

Roche acquired molecular diagnostics testing service provider Ariosa Diagnostics, Inc. based in San Jose, Calif.

BASEL, 3-12-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa),…

9 years ago

Roche acquires California-based Genia Technologies

Basel, 04-6-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the acquisition of Genia Technologies, Inc. (Genia), a privately…

10 years ago

Roche’s cobas HPV Test for first-line primary screening test for cervical cancer gets FDA approval

Expanded indication makes cobas HPV Test the only test approved in U.S. that can be used instead of Pap in…

10 years ago